Assistant Professor & Medical Oncologist at the National Cancer Centre #Singapore | Special interest in #CancerImmunology & #CellTherapy 📝: https://scholar.google.co.uk/citations?hl=en&user=kkncTrMAAAAJhttps://bsky.app/profile/sophiawongyn.bsky.socialhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3m3hcucools23⭐️Great first session on #AdoptiveCellTherapy chaired by Samra Turajlic Starting w/ @haanenjohn.bsky.social on #TIL #TCR, Sonia Guedan on #CART & Jeff Miller on #NKTherapy Academic manufacturing is possible! We need to work w/ industry/regulators to move closer to #cure 🔥 #ESMO2518 Oct 2025 07:57 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3m3hcucools23https://bsky.app/profile/sophiawongyn.bsky.social/post/3m3ff3keppc2wGreat talk by Sebastian Klobuch @sklobuch.bsky.social from @nkinl.bsky.social on #CellTherapy - so much still to learn and grow in this space 🙌🏼 @myesmo.bsky.social #ESMO2517 Oct 2025 13:32 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3m3ff3keppc2whttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lltmm6q3zk2pCongrats to Dr Steve Rosenberg & team for another outstanding study👏🏼 ✅Neoantigen reactive #TIL in #MMR proficient #GI cancers has sustained responses ✅Adding pembro increases responses ❗️Median time to Tx is 3-4m; more efforts needed to increase availability in our pts https://www.nature.com/articles/s41591-025-03627-502 Apr 2025 14:40 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lltmm6q3zk2phttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lkrepe5btc2iThank you @keystonesymposia.bsky.social for a wondering meeting. Lots of #immunology #celltherapy 💉🦠discussed! Now to get back to fun and exciting work back home 🇸🇬! Of course! Picture of @SunshineVillage ! #skiing ⛷️and #work combo is the best! 😍 Till next time! ❤️19 Mar 2025 23:49 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lkrepe5btc2ihttps://bsky.app/profile/sophiawongyn.bsky.social/post/3levvohm5cc2lDo check out our review on #celltherapy toxicities in solid cancers out now on #ESMO IO tech! [contains quote post or other embedded content]04 Jan 2025 10:32 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3levvohm5cc2lhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3ldasytedzk2hAwesome review on unconventional T cells! Breaking the mold in cancer therapy #CancerCell https://www.cell.com/cancer-cell/fulltext/S1535-6108%2824%2900445-8 Also check out @DrGopalIyer recent review on GD on #ESMO #IOTech A GD Type of Cancel Culture - https://www.esmoiotech.org/article/S2590-0188%2824%2900037-6/fulltext #CellTherapy #GammaDelta #NKT14 Dec 2024 07:53 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3ldasytedzk2hhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lczpos2vac2cCongrats @zaydtippu.bsky.social 👏🏼👏🏼👏🏼 [contains quote post or other embedded content]11 Dec 2024 12:05 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lczpos2vac2chttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lcq3oqwotc2mLet’s go! 🙌🏼🙌🏼🙌🏼 #CellTherapy #TILTherapy Welcome to 🦋🦋🦋 @drbetofmdphd.bsky.social @sklobuch.bsky.social [contains quote post or other embedded content]07 Dec 2024 16:13 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lcq3oqwotc2mhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lcngfci4ys2aWhat an honour hosting John Haanen #nki today #NCCS - talking all #celltherapy #TILtherapy & visiting our national GMP facility 👩🏻‍🔬 And a fascinating talk on myeloids in lung by @charlesswanton.bsky.social ☺️ #ESMOAsia2406 Dec 2024 14:47 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lcngfci4ys2ahttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lch26a6btk2rLooking forward to this debate tomorrow here in National Cancer #Singapore with a ⭐️ star-studded line up! 🔥 Register below and see you tomorrow! #CancerImmunotherapy #ESMOAsia #NCCS04 Dec 2024 01:52 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lch26a6btk2rhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lcda4vtukk2vGreat review and overview of EGFR mutant NSCLC - 20 years since its discovery! #EGFR #NSCLC https://www.nature.com/articles/s41571-024-00971-202 Dec 2024 13:28 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lcda4vtukk2vhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lc7dotswnk25Fascinating how this was 40 years ago! Truly inspiring and we will be delivering #celltherapy to our patients here in #Singapore too! #TILTherapy #cancerimmunotherapy [contains quote post or other embedded content]01 Dec 2024 00:21 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lc7dotswnk25https://bsky.app/profile/sophiawongyn.bsky.social/post/3lbt6jbjps22nAwesome review on combination strategies with ICB #CancerImmunotherapy #ImmuneCheckpoint [contains quote post or other embedded content]26 Nov 2024 04:16 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lbt6jbjps22nhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lbrvugp3ss2hGreat team and opportunity to work with! Do apply! 📝📝📝 [contains quote post or other embedded content]25 Nov 2024 16:09 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lbrvugp3ss2hhttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lbhu2kucfn2gLet’s go! 🦋 [contains quote post or other embedded content]21 Nov 2024 16:10 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lbhu2kucfn2ghttps://bsky.app/profile/sophiawongyn.bsky.social/post/3lbhtxa7dgz2gJoining the bandwagon on 🦋 @bsky.app #FullyOnboard #NewBeginnings21 Nov 2024 16:08 +0000at://did:plc:dfoss5dluymgvrxrndsohncp/app.bsky.feed.post/3lbhtxa7dgz2g